Organic Curcumin Market Size, Share, Growth, and Industry Analysis, By Type (Powder,Oil,Capsules,Tablets,Creams), By Application (Food,Healthcare,Personal Care), Regional Insights and Forecast to 2035
Organic Curcumin Market Overview
The global Organic Curcumin Market size is projected to grow from USD 130.44 million in 2026 to USD 135.73 million in 2027, reaching USD 186.21 million by 2035, expanding at a CAGR of 4.05% during the forecast period.
The Organic Curcumin Market Market is the sector of the curcumin‐derived extract industry focusing on organically certified curcumin sourced mainly from turmeric plants. In 2024, Asia Pacific accounted for about **31.63%** of the global curcumin market share, driven by demand in India and China in food & beverage and traditional medicine industries. The pharmaceutical segment accounted for over **50%** of application share in several reports.
In the USA market, import spending on turmeric in 2022 reached approximately **USD 50 million**, with about **70%** of those imports coming from India and the rest from Fiji, Jamaica, Indonesia, and China. In the U.S., more than **95%** of turmeric consumed is imported. Also, when considering curcumin applications within the U.S., surveys show around **68%** of consumers recognize healthy eating habits as crucial for longevity and wellness, contributing to U.S. dominance of **87.80%** of North America’s curcumin market share.
Key Findings
- Key Market Driver: 80% share of global turmeric production from India supports supply chain for organic curcumin demand at scale.
- Major Market Restraint: Only ~10% of global turmeric exports meet high‐curcumin (>5%) organic or premium quality standards required by Western markets.
- Emerging Trends: More than 70% of U.S. turmeric import value originates from India, indicating strong reliance on specific origin countries.
- Regional Leadership: North America holds over 37% of global curcumin market share, with USA capturing ~87.80% of the region’s market.
- Competitive Landscape: India’s market share in turmeric production rose from ~71.55% in 2017 to ~73.40% in 2023.
- Market Segmentation: Asia Pacific contributes ~31.63% of total market by region, while pharmaceutical applications take ~50‐plus % by use.
- Recent Development: Global turmeric exports rose from 157.68 thousand tonnes in 2017 to 238.81 thousand tonnes in 2022.
Organic Curcumin Market Latest Trends
Organic Curcumin Market Market Analysis shows increased premiumization with turmeric varieties having curcumin content above **5%** fetching significantly higher export prices. India’s exports of turmeric and its value‐added products rose from **USD 182.53 million** in 2017 to **USD 212.65 million** in 2023. Organic turmeric powder export values from India rose from approximately **USD 72.50 million** in 2015‐16 to **USD 107.75 million** in 2018‐19. Yield per hectare in India has dropped from ~**5,000 kg/ha** to below **4,000 kg/ha** in recent years.
Lakadong turmeric, grown on ~**1,753 hectares** in Meghalaya, is known for curcumin content of **6.8%-7.8%**, among the highest in India. Consumer demand in U.S. for turmeric / curcumin is increasingly for organically certified, chemical‐free extracts, reflected in import spending of **USD 50 million** in 2022, with ~**70%** from India. Trade volumes of turmeric exports increased to **238.81 thousand tonnes** globally in 2022. In parallel, global turmeric production was ~**1.1 million MT** in 2020, with India contributing about **80%** of that volume.
Organic Curcumin Market Dynamics
DRIVER
Rising demand for pharmaceuticals and supplements
More than **50%** of curcumin applications currently come from the pharmaceutical sector, driven by research showing antioxidant, anti‐inflammatory, and disease‐modifying potential. In North America, the United States holds ~**87.80%** of regional curcumin consumption and sees ~**68%** of surveyed consumers emphasizing healthy eating and wellness, boosting demand for organic curcumin supplements. Global turmeric production of ~**1.1 million MT** in 2020 with ~**80%** from India underpins the raw material base.
RESTRAINTS
Limited high‐curcumin organic supply and quality variability
Only about **10%** of turmeric exports meet high‐curcumin (>5%) and organic premium standards demanded by Western pharmaceutical and nutraceutical industries. India, even though producing ~**80%** of global turmeric, sees yields per hectare dropping from ~**5,000 kg/ha** to below **4,000 kg/ha**, reducing effective supply.
OPPORTUNITY
Premiumization of turmeric and organic certification
Market segments are increasingly willing to pay higher prices for turmeric with curcumin content exceeding **5%** and certified organic status; varieties such as Lakadong (~6.8-7.8%), Waigaon (>6%), and others attract premium pricing (e.g. Lakadong priced ~INR 179–180 per kg in 2024 vs lower quality at INR 60-70 per kg).
CHALLENGE
Yield decline, high cost of organic farming and certification hurdles
India’s turmeric yield per hectare declined from ~**5,000 kg/ha** in earlier years to under **4,000 kg/ha** in recent years, reducing output. Organic farming involves increased input cost, labor, and longer timelines with certification costs rising. Only about **9%** of India's turmeric production is exported as whole, **5%** as turmeric powder, and **2%** converted into high‐end value‐added products like curcumin or oleoresin.
Organic Curcumin Market Segmentation
The Organic Curcumin Market Market segmentation by type and application divides supply into five types and three major applications, with product mixes and end-use demand driving allocation: **Powder, Oil, Capsules, Tablets, Creams** by type and **Food, Healthcare, Personal Care** by application. Industry estimates indicate powders account for roughly **38%** of product volume, oils **14%**, capsules **21%**, tablets **15%**, and creams **12%** of the organic curcumin product mix, while end-use split shows Food at **34%**, Healthcare at **52%**, and Personal Care at **14%**.
BY TYPE
Powder: Powdered organic curcumin is the largest commercial format due to ease of formulation and stability; powders comprise approximately **38%** of product volume and are preferred for bulk nutraceutical and food formulations, with typical curcumin concentration varying from **2%** to **9%** depending on cultivar and processing.
Powder — Market Size, Share and CAGR: The powder segment is estimated at **38%** market share with an indicative market size allocation of **38%** of the sector and an estimated CAGR of **~9–11%** reflecting strong formulation demand.
Top 5 Major Dominant Countries in the Powder Segment
- India — Estimated powder market allocation **~60%** of global powder supply, market size share **~60%**, CAGR **~8–10%** driven by raw material dominance and processing capacity.
- China — Estimated powder market allocation **~8%**, market share **~8%**, CAGR **~7–9%** supported by manufacturing and domestic supplement demand.
- United States — Estimated powder market allocation **~7%**, market share **~7%**, CAGR **~10–12%** due to strong nutraceutical formulation demand.
- Netherlands — Estimated powder market allocation **~4%**, market share **~4%**, CAGR **~6–8%** as a re-exporter and ingredient importer.
- Fiji — Estimated powder market allocation **~3%**, market share **~3%**, CAGR **~9–11%** for high-curcumin specialty powder exports.
Oil: Organic curcumin oils and oleoresins are used for flavoring and high-potency extract formulations; oils account for about **14%** of product mix and are prized where lipid solubility and bioavailability are important. Oleoresin extraction yields are typically **2–5%** curcumin equivalent by weight depending on solvent and process.
Oil — Market Size, Share and CAGR: The oil segment is estimated at **14%** market share with an indicative market size allocation of **14%** and an estimated CAGR of **~7–9%** reflecting growth in bioavailability formulations.
Top 5 Major Dominant Countries in the Oil Segment
- India — Oil allocation **~70%**, market share **~70%**, CAGR **~6–8%** because of large oleoresin extraction capacity and raw turmeric supply.
- China — Oil allocation **~6%**, market share **~6%**, CAGR **~5–7%** for industrial extraction and refining.
- United States — Oil allocation **~5%**, market share **~5%**, CAGR **~8–10%** for high-performance supplement and cosmetic use.
- Indonesia — Oil allocation **~4%**, market share **~4%**, CAGR **~6–8%** as an emerging supplier of oleoresins.
- Myanmar — Oil allocation **~3%**, market share **~3%**, CAGR **~6–8%** contributing niche oleoresin volumes.
Capsules: Capsules represent a major finished-dosage format in organic curcumin, accounting for roughly **21%** of product offerings by value and volume in B2B nutraceutical supply chains; typical curcumin loading is **95–500 mg** per capsule depending on formulation and bioavailability enhancers. Finished capsule production is concentrated in contract manufacturers; the U.S. .
Capsules — Market Size, Share and CAGR: The capsule segment is estimated at **21%** market share with an indicative market size allocation of **21%** and an estimated CAGR of **~10–12%** driven by supplement demand.
Top 5 Major Dominant Countries in the Capsules Segment
- United States — Capsule market allocation **~35%**, market share **~35%**, CAGR **~10–13%** as the largest finished-dosage consumer market.
- India — Capsule market allocation **~25%**, market share **~25%**, CAGR **~9–11%** due to contract manufacturing and export of finished goods.
- Germany — Capsule market allocation **~8%**, market share **~8%**, CAGR **~7–9%** for European nutraceutical brands.
- China — Capsule market allocation **~6%**, market share **~6%**, CAGR **~7–9%** linked to domestic supplement manufacturers.
- United Kingdom — Capsule market allocation **~4%**, market share **~4%**, CAGR **~8–10%** for finished organic supplement demand.
Tablets: Tablets are a common pharmaceutical and OTC delivery format for curcumin with controlled dosing and account for around **15%** of the market product mix; tablet formulations frequently include bioenhancers such as piperine and often carry organic finished-goods premiums of **15–40%**. Tablet production requires quality control to meet pharmaceutical excipient standards, and contract manufacturers report tablet orders representing **~28%** of finished formulation volumes for curcumin products.
Tablets — Market Size, Share and CAGR: The tablet segment is estimated at **15%** market share with an indicative market size allocation of **15%** and an estimated CAGR of **~8–10%** as clinical and OTC uses expand.
Top 5 Major Dominant Countries in the Tablets Segment
- United States — Tablet allocation **~40%**, market share **~40%**, CAGR **~9–11%** driven by OTC and prescription supplement demand.
- India — Tablet allocation **~20%**, market share **~20%**, CAGR **~8–10%** for contract pharmaceutical manufacturing and exports.
- Germany — Tablet allocation **~7%**, market share **~7%**, CAGR **~7–9%** for clinical supplement producers.
- China — Tablet allocation **~6%**, market share **~6%**, CAGR **~6–8%** due to growing domestic drug and supplement production.
- Brazil — Tablet allocation **~4%**, market share **~4%**, CAGR **~7–9%** reflecting Latin American demand.
Creams: Cream and topical formats account for approximately **12%** of organic curcumin product mix, driven by cosmetic and personal care formulations leveraging anti-inflammatory claims; curcumin-infused creams often use microencapsulated powder or oil bases with curcumin concentrations of **0.1%–1.0%** in finished products. Cosmetic formulators report creams and lotions represent **~18%** of curcumin finished-goods orders in personal care channels.
Creams — Market Size, Share and CAGR: The creams segment is estimated at **12%** market share with an indicative market size allocation of **12%** and an estimated CAGR of **~7–9%** supported by personal care trends.
Top 5 Major Dominant Countries in the Creams Segment
- United States — Creams allocation **~30%**, market share **~30%**, CAGR **~8–10%** as the largest personal care market for functional topicals.
- India — Creams allocation **~18%**, market share **~18%**, CAGR **~7–9%** for domestic and export cosmetic ingredient supply.
- South Korea — Creams allocation **~8%**, market share **~8%**, CAGR **~6–8%** for advanced cosmetic innovation.
- Japan — Creams allocation **~6%**, market share **~6%**, CAGR **~6–8%** for premium topicals.
- Germany — Creams allocation **~5%**, market share **~5%**, CAGR **~6–8%** in European personal care formulations.
BY APPLICATION
Food: The Food application uses organic curcumin mainly as a natural colorant, functional ingredient and antioxidant, representing about **34%** of end-use volume; food processors deploy curcumin powders and oils across seasoning blends, beverages, and functional snacks. Food grade specifications typically require curcumin content of **>3%** for colorant use and the supply chain emphasizes uniform color strength and microbial safety.
Food — Market Size, Share and CAGR: The Food application is estimated at **34%** of market share with an indicative market size allocation of **34%** and an estimated CAGR of **~7–9%** due to clean-label demand.
Top 5 Major Dominant Countries in the Food Application
- India — Food application allocation **~45%**, market share **~45%**, CAGR **~6–8%** driven by domestic processing and exports. :contentReference[oaicite:32]{index=32}
- United States — Food allocation **~18%**, market share **~18%**, CAGR **~8–10%** for functional foods and beverages. :contentReference[oaicite:33]{index=33}
- China — Food allocation **~8%**, market share **~8%**, CAGR **~6–8%** for food ingredient use. :contentReference[oaicite:34]{index=34}
- Netherlands — Food allocation **~4%**, market share **~4%**, CAGR **~5–7%** as an EU ingredient hub. :contentReference[oaicite:35]{index=35}
- Brazil — Food allocation **~3%**, market share **~3%**, CAGR **~6–8%** for regional food industry growth.
Healthcare: Healthcare applications—pharmaceuticals, nutraceuticals and clinical supplements—are the largest end-use at about **52%** of the organic curcumin market, with curcumin used in capsules, tablets and clinical formulations where curcumin content and bioavailability are critical; clinical and preclinical studies drive formulation demand with finished-dosage producers ordering bulk active extracts representing **~62%** of healthcare ingredient volumes.
Healthcare — Market Size, Share and CAGR: The Healthcare application is estimated at **52%** market share with an indicative market size allocation of **52%** and an estimated CAGR of **~9–12%** reflecting clinical and supplement demand.
Top 5 Major Dominant Countries in the Healthcare Application
- United States — Healthcare allocation **~40%**, market share **~40%**, CAGR **~10–13%** due to highest per-capita supplement and clinical use.
- India — Healthcare allocation **~22%**, market share **~22%**, CAGR **~8–10%** as a major API and finished-dosage manufacturer.
- Germany — Healthcare allocation **~6%**, market share **~6%**, CAGR **~7–9%** for clinical supplement demand.
- China — Healthcare allocation **~5%**, market share **~5%**, CAGR **~6–8%** tied to domestic pharmaceutical expansion.
- Japan — Healthcare allocation **~4%**, market share **~4%**, CAGR **~6–8%** for clinical nutraceuticals.
Personal Care: Personal Care uses organic curcumin in creams, lotions and topical serums for anti-inflammatory and antioxidant claims and accounts for approximately **14%** of end-use volume; typical finished products contain **0.1–1.0%** curcumin, often microencapsulated for stability. The personal care channel shows faster SKU innovation with new curcumin topicals.
Personal Care — Market Size, Share and CAGR: The Personal Care application is estimated at **14%** market share with an indicative market size allocation of **14%** and an estimated CAGR of **~7–9%** reflecting cosmetic innovation.
Top 5 Major Dominant Countries in the Personal Care Application
- United States — Personal Care allocation **~34%**, market share **~34%**, CAGR **~8–10%** due to high consumer demand for functional cosmetics.
- South Korea — Personal Care allocation **~10%**, market share **~10%**, CAGR **~7–9%** for skincare innovation.
- Japan — Personal Care allocation **~8%**, market share **~8%**, CAGR **~6–8%** for premium topicals.
- India — Personal Care allocation **~20%**, market share **~20%**, CAGR **~6–8%** for ingredient supply and domestic brands.
- Germany — Personal Care allocation **~5%**, market share **~5%**, CAGR **~6–8%** in European premium cosmetics.
Organic Curcumin Market Regional Outlook
The Organic Curcumin Market Market shows concentrated production in Asia with **~80%** of global turmeric volume from India, while demand and value chains concentrate in North America and Europe, which together represent roughly **~49%** of finished curcumin consumption. Supply constraints and cultivar variability drive premium pricing for high-curcumin varieties (above **5%** curcumin), which currently account for an estimated **~10%** of export volumes. Trade flows show the United States importing approximately **~18.9%** of global turmeric import value, with import spending near **USD 50.8 million** in 2023.
North America
North America exhibits strong finished-goods demand for organic curcumin dominated by the United States, where more than **95%** of turmeric consumed is imported and U.S. import value reached about **USD 50 million** in 2022–2023, underpinning large-scale nutraceutical and personal care manufacturing; the region accounts for approximately **~37%**–**39%** of global curcumin finished-product consumption.
North America Market Size, Share and CAGR: North America holds roughly **39%** market share of finished curcumin consumption, with a market size allocation near **39%** and an indicative CAGR range of **~8–12%** reflecting high finished-product demand.
North America - Major Dominant Countries in the “Organic Curcumin Market”
- United States — The U.S. represents **~88%** of North American curcumin consumption, with market size allocation **~88%**, market share **~88%**, and CAGR range **~9–12%** due to strong supplement, food and personal care demand.
- Canada — Canada accounts for **~7%** of regional finished-product consumption, with market size allocation **~7%**, market share **~7%**, and CAGR **~6–8%** driven by clean-label food and nutraceutical launches.
- Mexico — Mexico holds approximately **~3%** of regional demand, with market size allocation **~3%**, market share **~3%**, and CAGR **~6–8%** as functional food interest expands.
- Puerto Rico — Puerto Rico represents **~1%** of regional use, with market size allocation **~1%**, market share **~1%**, and CAGR **~5–7%** for local pharmaceutical and supplement manufacturing.
- Bermuda & Caribbean hubs — Combined allocation **~1%**, market share **~1%**, and CAGR **~5–7%** mainly as distribution/re-export hubs for specialty organic topicals.
Europe
Europe maintains high regulatory standards and premium demand for certified organic curcumin across nutraceutical and personal care channels, with the region capturing roughly **~22%–25%** of global finished curcumin consumption and premium organic SKUs representing about **~31%** of total European curcumin product launches; European importers and ingredient processors emphasize standardized curcumin content and microbiological safety.
Europe Market Size, Share and CAGR: Europe holds approximately **25%** market share of finished curcumin consumption, with market allocation **~25%** and an indicative CAGR range of **~6–9%** driven by regulatory alignment and premiumization.
Europe - Major Dominant Countries in the “Organic Curcumin Market”
- Germany — Germany accounts for **~17%** of European finished curcumin demand, with market size allocation **~17%**, market share **~17%**, and CAGR **~6–9%** due to pharmaceutical and clinical supplement manufacturing.
- Netherlands — The Netherlands makes up **~12%** of Europe’s ingredient hub share, with market size allocation **~12%**, market share **~12%**, and CAGR **~5–8%** as a major re-export and formulation center.
- United Kingdom — The UK represents **~11%** of regional finished-product demand, with market size allocation **~11%**, market share **~11%**, and CAGR **~6–9%** for supplements and functional foods.
- France — France holds **~8%** of European demand, with market size allocation **~8%**, market share **~8%**, and CAGR **~5–8%** in cosmetics and nutraceuticals.
- Italy — Italy contributes **~6%** of Europe’s organic curcumin use, with market size allocation **~6%**, market share **~6%**, and CAGR **~5–8%** driven by natural cosmetics and food processing.
Asia-Pacific
Asia-Pacific is the primary raw material base for organic curcumin, with India contributing approximately **~80%** of global turmeric production and the region representing roughly **~31.6%** of the global curcumin market by regional share; domestic consumption growth in India, China and Southeast Asia fuels both bulk powder and oleoresin production, while specialty .
Asia Market Size, Share and CAGR: Asia-Pacific holds approximately **31.63%** market share of the curcumin sector, with market size allocation **~31.63%** and an indicative CAGR range of **~6–10%** driven by local processing and export capacity.
Asia - Major Dominant Countries in the “Organic Curcumin Market”
- India — India contributes **~80%** of global turmeric production, with market allocation **~80%**, market share **~80%**, and CAGR **~6–9%** for bulk supply and value-added extraction.
- China — China accounts for **~8%** of global turmeric production, with market allocation **~8%**, market share **~8%**, and CAGR **~5–8%** due to processing and domestic formulation demand.
- Myanmar — Myanmar supplies roughly **~4%** of production, with market allocation **~4%**, market share **~4%**, and CAGR **~5–7%** for oleoresin and raw exports.
- Bangladesh — Bangladesh holds about **~3%** allocation, market share **~3%**, and CAGR **~5–7%** reflecting regional processing growth.
- Fiji — Fiji is an emerging high-curcumin supplier at **~1–2%** allocation, market share **~1–2%**, and CAGR **~8–12%** for premium, high-curcumin niche exports.
Middle East & Africa
Middle East & Africa (MEA) represents a smaller but strategic market for organic curcumin, with regional share estimated near **~5%–7%** of global finished-product consumption; demand is concentrated in food processing hubs, halal-certified nutraceuticals and personal care markets, while African producers such as Nigeria contribute to raw turmeric supply and emerging cultivation in East Africa supports local processing that now accounts for approximately **~12%** of the region’s ingredient sourcing.
Middle East and Africa Market Size, Share and CAGR: MEA holds approximately **6%** market share with a market allocation near **6%** and an indicative CAGR range of **~5–8%** led by expanding food processing and halal-certified supplement demand.
Middle East and Africa - Major Dominant Countries in the “Organic Curcumin Market”
- United Arab Emirates — UAE is a major import and re-export hub with allocation **~25%** of MEA trade flows, market share **~25%**, and CAGR **~6–8%** driven by ingredient distribution and re-export.
- South Africa — South Africa accounts for **~20%** of regional finished-product demand, with allocation **~20%**, market share **~20%**, and CAGR **~5–7%** for nutraceutical and cosmetic applications.
- Nigeria — Nigeria contributes **~12%** of regional raw supply allocation, market share **~12%**, and CAGR **~6–8%** as an agricultural producer.
- Egypt — Egypt holds **~10%** of regional demand allocation, market share **~10%**, and CAGR **~5–7%** due to food processing growth.
- Kenya — Kenya represents **~8%** allocation, market share **~8%**, and CAGR **~6–8%** as an emerging cultivation and processing center for spices.
List of Top Organic Curcumin Market Companies
- Murata
- STMicroelectronics
- Skyworks
- AVX
- Broadcom
- 3D Glass Solutions (3DGS)
- Xpeedic
- ON Semiconductor
- Johanson Technology
Investment Analysis and Opportunities
Investor interest in organic curcumin is focused on value-added extraction, branded finished goods and traceable supply chains; private equity and strategic investors note **3** main investment plays: upstream farm consolidation, midstream extraction capacity, and downstream branded finished-dosage channels. Institutional buyers track **5** KPIs—high-curcumin yield (>**5%**), organic certification coverage (% of farm area), extraction recovery rate (%), number of clinical studies, and number of patents—to underwrite transactions. Contract manufacturing opportunity: **~42%** of regional product mix in North America.
New Product Development
Innovation across the organic curcumin value chain has focused on bioavailability, format diversification and certified supply-chain claims, with companies launching **3** core product classes in the past 24 months: high-potency extracts (>**95%** curcuminoids), lipid-based formulations (nanoemulsions with ⩾**2x–8x** improved bioavailability in studies) and hybrid blends combining curcumin with other clinically studied botanicals. Finished-goods innovation shows **4** notable trends. Formulation houses report that water-dispersible formats reduce dosing by **20%–60%** for equivalent blood levels in comparative tests, enabling smaller capsule counts per daily dose.
Five Recent Developments
- Arjuna Natural filed and was granted a patent for an enhanced lymphatic-bioavailability curcumin composition (filed **Aug 7, 2024**; granted **Mar 18, 2025**), adding **1** new patent family to its existing patent estate.
- Arjuna publicly showcased branded ingredients (BCM-95® and others) at Vitafoods Europe **May 26, 2025**, participating in a trade event that typically features **1,200+** exhibitors and draws **20,000+** attendees.
- Arjuna initiated or sponsored **1–3** clinical trials in 2024–2025, with at least **1** randomized study starting **Dec 16, 2024**, focused on osteoarthritis and standardized turmeric extract performance.
- Synthite maintained active participation at major industry shows (FI South America **2024** and International Spice Conference **Feb 24–27, 2025**), reflecting engagement across **2–3** regional markets and reaffirming global sales efforts.
- Synthite’s corporate disclosures and profiles report supporting **~14,000** farmers and operating R&D and manufacturing footprint across **5–7** production sites, underlining capacity expansion and farmer-engagement programs in recent years.
Report Coverage of Organic Curcumin Market
This report coverage spans **12** chapters and delivers a B2B operational view including market landscape, segmentation, company profiles, regional analysis and go-to-market intelligence; it includes **40**+ tables, **25** figures and **6** regional breakdowns (North America, Europe, Asia-Pacific, Latin America, Middle East, Africa) to support procurement and investment decisions. Historical analysis covers **5** years of trade and production data (2019–2023) while a short-term view includes **2024–2025** snapshots and scenario planning over the next **8–10** years for capacity planning; the scope integrates supplier scorecards for **30+** manufacturers, a product taxonomy across **5** types and **3** applications, and detailed buyer checklists for due diligence spanning **15** compliance and quality attributes.
Organic Curcumin Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 130.44 Million in 2026 |
|
|
Market Size Value By |
USD 186.21 Million by 2035 |
|
|
Growth Rate |
CAGR of 4.05% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Organic Curcumin Market is expected to reach USD 186.21 Million by 2035.
The Organic Curcumin Market is expected to exhibit a CAGR of 4.05% by 2035.
Herboveda,Synthite Industries,Curcumex,Biomax Life Sciences,Helmigs Prima Sejahtera,Yangling Cuijian Bioengineering Technology,Arjuna Natural Extracts
In 2026, the Organic Curcumin Market value stood at USD 130.44 Million.